Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iridium Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110590821A details mild iridium-catalyzed synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing with stable raw materials and high purity.
Patent CN103724264A details iridium-catalyzed asymmetric hydrogenation for high-purity chiral tetrahydroisoquinoline derivatives, offering significant cost reduction and supply chain reliability.
Patent CN110862324A discloses a novel iridium-catalyzed asymmetric reductive amination method achieving up to 95% ee for key pharmaceutical intermediates like Cinacalcet.
Patent CN115160162A details an iridium-catalyzed method for synthesizing chiral beta-hydroxy alpha-amino acid derivatives with high enantioselectivity, offering significant cost reduction in API manufacturing.
Patent CN110551033B details a novel Ir-catalyzed asymmetric reductive amination method. Achieve high enantioselectivity and cost reduction in chiral amine manufacturing with scalable processes.
Patent CN113461681A reveals efficient iridium-catalyzed C-H amination using ionic liquids, offering high purity pharmaceutical intermediates with reduced processing costs.
Patent CN119431279B reveals a novel Ir-catalyzed asymmetric hydrogenation route for chiral cyclic ethers, offering superior purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN103420908A reveals a high-yield asymmetric hydrogenation route for Montelukast intermediates, offering significant cost reduction and supply chain reliability for API manufacturers.
Novel C-H amination method for gamma/delta-lactams offers high selectivity and cost-effective routes for complex API intermediates.
Patent CN106699628A reveals efficient levulinic acid conversion. Lower temperature, high yield pyrrolidone synthesis for reliable supply chain.
Patent CN111170918A details a cost-effective iridium-catalyzed C-H amination route for lactams, offering significant supply chain stability and reduced manufacturing costs for pharma intermediates.
Patent CN111574487B details a novel asymmetric hydrogenation method for producing high-purity chiral dihydroisoflavones, offering significant supply chain and cost advantages.
Novel iridium-catalyzed method offers high enantioselectivity. Reduces waste and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel iridium-catalyzed hydrogen transfer cyclization for tetrahydroquinoline pyrans. High atom economy, one-pot synthesis, ideal for reliable pharmaceutical intermediate supply chains.
Patent CN113980044B reveals a novel Ir-O-P catalyzed diboration method. This breakthrough enables cost-effective, scalable production of high-purity organoboron intermediates for drug discovery.
Patent CN111072450B reveals a high-yield iridium-catalyzed route for allyl alcohol derivatives, offering significant cost reduction and supply chain stability for pharmaceutical intermediates.
Patent CN116375653A details a high enantioselective iridium-catalyzed method for chiral tetrahydroquinazoline derivatives, offering cost-effective API intermediate manufacturing solutions.
Patent CN111925308B reveals a mild iridium-catalyzed photocatalytic route for N-substituted sulfone diimines, offering reliable pharmaceutical intermediate supply chains.
Patent CN113980044B details a novel Ir-O-P catalyzed C-H borylation method offering high yields and broad substrate scope for pharmaceutical intermediates.
Discover how novel C-H activation methods for polysubstituted isoquinolines reduce catalyst costs and improve yield in pharmaceutical synthesis. Contact us for custom manufacturing.